Rice Hall James & Associates, LLC Amicus Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

$1.69 Billion
Q3 2024

A detailed history of Rice Hall James & Associates, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Rice Hall James & Associates, LLC holds 972,138 shares of FOLD stock, worth $8.77 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

972,138

Previous 972,284 0.02%

Holding current value

$8.77 Million

Previous $9.65 Million 7.64%

% of portfolio

0.61%

Previous 0.63%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$9.55 - $12.09 $1,394 - $1,765	-146 Reduced 0.02%	972,138 $10.4 Million
Q2 2024 Aug 07, 2024	SELL	$9.04 - $11.75 $508,816 - $661,348	-56,285 Reduced 5.47%	972,284 $9.65 Million
Q1 2024 Apr 23, 2024	SELL	$11.43 - $14.24 $427,436 - $532,519	-37,396 Reduced 3.51%	1,028,569 $12.1 Million
Q4 2023 Feb 08, 2024	SELL	$9.97 - $14.52 $128,613 - $187,308	-12,900 Reduced 1.2%	1,065,965 $15.1 Million
Q3 2023 Nov 02, 2023	BUY	$11.78 - $13.86 $355,779 - $418,599	30,202 Added 2.88%	1,078,865 $13.1 Million
Q2 2023 Jul 24, 2023	BUY	$10.72 - $13.3 $2.16 Million - $2.68 Million	201,804 Added 23.83%	1,048,663 $13.2 Million
Q1 2023 May 11, 2023	BUY	$10.91 - $13.54 $1.52 Million - $1.88 Million	138,971 Added 19.63%	846,859 $9.39 Million
Q4 2022 Jan 27, 2023	SELL	$9.89 - $12.7 $64,492 - $82,816	-6,521 Reduced 0.91%	707,888 $0
Q3 2022 Nov 01, 2022	SELL	$9.82 - $12.75 $1.96 Million - $2.55 Million	-199,866 Reduced 21.86%	714,409 $7.46 Million
Q2 2022 Aug 08, 2022	BUY	$6.23 - $11.12 $1.77 Million - $3.17 Million	284,658 Added 45.21%	914,275 $9.82 Million
Q1 2022 May 05, 2022	BUY	$7.89 - $12.48 $113,773 - $179,961	14,420 Added 2.34%	629,617 $5.96 Million
Q4 2021 Feb 14, 2022	SELL	$9.82 - $12.44 $311,303 - $394,360	-31,701 Reduced 4.9%	615,197 $7.11 Million
Q3 2021 Nov 09, 2021	SELL	$8.74 - $11.84 $32,530 - $44,068	-3,722 Reduced 0.57%	646,898 $6.18 Million
Q2 2021 Jul 29, 2021	SELL	$8.71 - $10.72 $1.23 Million - $1.51 Million	-140,747 Reduced 17.79%	650,620 $6.27 Million
Q1 2021 May 14, 2021	BUY	$9.2 - $23.86 $1.83 Million - $4.74 Million	198,835 Added 33.56%	791,367 $7.82 Million
Q4 2020 Feb 16, 2021	BUY	$13.47 - $24.89 $7.98 Million - $14.7 Million	592,532 New	592,532 $13.7 Million

Others Institutions Holding FOLD

# of Institutions

311

Shares Held

314M

Call Options Held

516K

Put Options Held

833K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.53B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rice Hall James & Associates, LLC with notifications on news.

Account

Rice Hall James & Associates, LLC Amicus Therapeutics, Inc. Transaction History